Introduction
Gestational trophoblastic disease (GTD) is a group of conditions associated with abnormal pregnancy, histologically; it includes the benign partial and complete hydatidiform mole, invasive mole, as well as the malignant choriocarcinoma. Molar pregnancies may develop persistent elevated serum human chorionic gonadotropin (hCG) levels after evacuation (complete mole 15%−20%, partialmole 0.1%−5%), with a chance of progression to choriocarcinoma. Complete mole has florid trophoblastic proliferation, and absence of fetal parts. In contrast, such histological features are less marked in partial mole and fetal parts are present, such as fetal cells. Hydropic spontaneous abortion may mimic the appearance of partial mole. 1 Choriocarcinoma is a malignant tumor with the absence of chorionic villi, abnormal syncytiotrophoblast and cytotrophoblast, necrosis, and hemorrhage. It may invade the uterus and surrounding organs and it is common to have distant spread, particularly to the lung, but it may also Background and objective: Trophoblastic diseases constitute a spectrum of tumors and tumor-like conditions characterized by proliferation of pregnancy associated trophoblastic tissue of progressive malignant potential. This study aimed to assess the value of p53 protein immunoexpression in the diagnosis of hydatidiform molar pregnancy and the differential diagnosis of its subtypes (complete and partial) from abortions. Methods: A cross-sectional study of tissue sections from 68 formalin-fixed, paraffin-embedded specimens of products of conception, including 1st trimester abortion (n=15), partial hydatidiform mole PHM (n=24), complete hydatidiform CHM (n=24) and full term placenta (n=5), all were examined at the Histopathology Department of Maternity Teaching Hospital in Erbil, Iraq during the period of Jan.2013-Jun.2013. Immunohistochemistry was performed using p53 antibody and the standard streptavidin-biotin immunoperoxidase method. The labeling index (number of positive nuclei/total number of nuclei) for villous cytotrophoblasts, syncytiotrophoblasts and stromal cells were evaluated separately. Statistical analysis was carried out by one way ANOVA and Fisher's exact tests, statistical significance was determined at P ≤0.05. Results: All villous trophoblastic lesions showed higher p53 immunoexpression in all villous components especially cytotrophoblasts, being the highest in complete hydatidiform mole (>50%) and partial hydatidiform mole (>20%). A statistically significant difference was found in immunoexpressins of p53 that was useful in separating abortion from complete hydatidiformmole, P <0.001, and partial hydatidiform mole, P <0.0002. It was also useful in separating between the complete hydatidiform mole and partial hydatidiform mole (P <0.001). Conclusion: p53 immunoexpression was valuable in differentiation between molar and non molar pregnancies and between subtypes of molar pregnancies. Keywords: Hydatidiform Mole; Abortion; p53; Immunohistochemistry. Sanarya M. Ali * Nadya Y. Ahmedi ** Tenya T. Abdulhameed ** Tara M.Shalal ** involve the liver, spleen, kidneys, bowels, and brain. 2 Accurate diagnosis and classification of HM is important as the risk of persistent gestational trophoblastic disease, including the CC, is significantly high. The risk of CC in CHM is 10% -30% and in PHM is 0.5% -5%. 3 Despite well-described histopathologic criteria, the distinction of spontaneous abortion from HM and CHM from PHM remains a problem because of interobserver and intraobserver variability. 4 Thus, development of new methods that allow differentiating these pathologies in doubtful cases is important. A complementary method to the pathologic interpretation is immunohistochemistery (IHC). Among the immunohistochemical markers, tumor suppressor proteins such as p53 have been investigated for this purpose. The p53 gene is important for several reasons including, genomic stability, transactivation of genes involved in cell cycle regulation, DNA repair, apoptosis, effectiveness of chemotherapy and prognosis of the disease. 5 Mutation of p53 gene has been reported in a variety of human malignant tumors and is frequently associated with over expression of p53 protein.
The extended half-life of mutant p53 protein allows it to accumulate to high concentration within the nuclei of affected cells, and it can be readily detected by IHC with antibodies specific to p53 protein; however in normal cells, p53 protein has a short intracellular half-life and such a low steady state level is usually not detectable by IHC. The immunohistochemical reactivity of p53 has been demonstrated to be associated with poor prognosis in many tumors 6 and p53 gene mutation might be involved in the pathogenesis of trophoblastic diseases. 7 This study aimed to assess the value of p53 protein immunoexpression in the diagnosis of hydatidiform molar pregnancy and the differential diagnosis of its subtypes (complete and partial) from abortions.
Methods
Sixty eight formalin-fixed, paraffinembedded tissue blocks of products of conception were chosen by simple random selection from files of pathology department of Maternity Teaching Hospital, Erbil, Iraq during the period from Jan. 2013-Jun.2013.The studied cases were categorized into the following groups: 1 st trimester abortion (n=15), PHM (n=24), CHM (n=24), in addition, 5 samples of full term placenta were included as a negative control. New sections were made from the most representative tissue block which identified that contains suitable materials without necrotic and haemorrhagic areas, thick areas or overlapping areas, then stained with haematoxylin and eosin (H&E) and histopathologicaly evaluated, another thin 4 µm section done and submitted for IHC. The study was approved by the Ethical Committee of the College of Medicine, Hawler Medical University, Erbil, Iraq. Immunohistochemistry was performed using the avidin-biotin-peroxidase complex according to a previously described protocol by Hsu et al 8 in which primarily monoclonal antibodies raised against p53 (DakoCytomation, Denmark, clone DO-7) was used and according to DakoCytomationEnVisionR+Dual link system-HRP (DAB+) staining protocol for immunostaining. With each batch of stain positive and negative control sections were incubated. Negative controls were obtained by omitting the primary antibody and by using N-Universal negative control, positive controls tissues specimens for P53 were prepared using invasive ductal carcinoma of the breast already stained for P53 and contained more than 50% tumor cells. Positive expression of P53 gives nuclear staining of brown color. Positive cells were determined by counting 1000 tumor cells, all significantly stained cells were considered positive and divided by 10 to decide whether the case was positive, at least 10 HPF were examined (with 400x) in each case for the purpose of scoring. The p53 labeling index (LI) in abortion and lesions of villous trophoblasts were evaluated separately for cytotrophoblasts, syncytiotrophoblasts, and stromal cells by counting 1000 cells for each population. The distribution of p53 immunoreactivity in trophoblastic diseases were quantitatively assessed as -ve (equal or less than 10% are positive cells) and +ve (more than 10% are positive cells) and the positive cases were graded as: + (10-20%); ++ (20-50 %); and +++ (more than 50%) are positive cells. Statistical analysis: -Data were analyzed using the statistical package for social sciences (SPSS, version 19). One way ANOVA and Tukey HSD Post-hoc tests were used to compare the means of p53 LI of cytotrophoblasts, syncytiotrophoblasts and stromal cells of trophoblastic villi among different groups (CHM, PHM and Abortions). Also, the results obtained from each case groups were compared in pairs for the following parameters included in the study (p53 LI and distribution of p53 immunostaining) by means of Fischer exact test. A P value of ≤0.05 was considered as statistically significant, and a P value <0.01 was considered as statistically highly significant.
Results
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A total of 68 specimens of placental trophoblastic tissues were included in this study: 1st trimester abortion (n=15), PHM (n=24), CHM (n=24) and full term placenta (n=5) as a negative control. The mean age (± SD) for abortion was 29.6 ± 3.7yrs, range: (20 - Tukey HSD Post hoc test shows a high statistical difference in p53 LI means of all villous components; especially cytotrophoblasts between abortion and PHM (P = 0.0002), abortion and CHM (P = 0.001) and PHM with CHM (P = 0.001) as shown in Table 2 , 3 and 4. expression between (10%-50%) in cytotrophoblasts; only one case of PHM (5%) had p53 immunreactivity above 50%. In order to study the role of p53 immunoexpression in differentiating these trophoblastic lesions, the data of these three groups (PHM, CHM, and abortion) were analyzed, matched in pairs and evaluated to their p53 expressions and the result of statistical analysis are summarized in Table (5) . A highly significant statistical difference present between p53 expression of all villous components of abortion and CHM P <0.01; also significant differences between p53 immunoexpression of all villous components of abortion and PHM and those of PHM and CHM P <0.05.
forms, each with its own risk of mortality and responsiveness to chemotherapy. Differential diagnosis of these diseases by routine histopathologic examination can be challenging. Studies have recently shown that IHC for various markers is useful for confirming the diagnosis and is a complementary method to pathologic interpretation. 9 In this study, the mean age of patients with molar pregnancy was 29.03 for PHM and 31.04 for CHM and the majority of them were between 20-40 years, Hasanyadeh et al, 2013 showed similar range, 10 while others showed reverse range results. 11, 12 All full term placenta specimens showed negative p53 immunostaining in all components of villi while the first trimester abortions showed mild positive nuclear p53 immunostaining of all villous components with a LI =11.2,6.6,4.7 in cytotrophoblasts, syncytiotrophoblastsand stromal cells respectively. This indicated that p53 plays a role in apoptosis but not normal as apoptotic proteins. Chen et al., 2011 also observed a positive p53 immunoexpression in the nuclei of cytotrophoblast cells and intermediate trophoblasts of abortions and no p53 expression was seen in normal placenta. 13 While another study showed a negative p53 immunoexpression in syncytiotrophoblasts with a few positivity in cytotrophoblasts in abortions. 14 In molar villous trophoblastic diseases, P53 LI was who showed that all cases of PHM and CHM were positive for P53. 9 The highest p53 LI was in cytotrophoblasts of CHM (71.2) followed by PHM (29.0), the lowest P53 LI was observed in stromal cells of villi in all villous lesion, while P53 LI in syncytiotrophoblasts was in between in both PHM and CHM. Statistically, there was a highly significant difference between 1 st trimester abortion and molar villous trophoblastic lesions regarding p53 LI means in all villous component (P <0.001); indicating that P53 LI, especially that of cytotrophoblasts, is the best index in separating these three entities. By taking 10% as a cut-off value, over expression was seen in 40% of 1 st trimester abortion, 80% PHM, and 100% for CHM cases. Other researchers use 10.8% as a cut off value for positive p53 protein immunoexpression. 7 Petignat et al., 2006 was in agreement with our result in which he found p53 overexpression in HM cases (93% of CHM and 80% of PHM) in cytotrophoblasts as compared with normal trophoblast; but focally expressed in syncytiotrophoblasts. 15 Also Al-Bozom, 2000 showed overexpression of p53 in 93% of CHM and 57% of PHM cases while none of non-molar pregnancies express p53. 16 Halperin et al., 2000 showed p53 overexpression in nuclei of villous trophoblast in all samples of CHM, 50% of PHM and 30% of normal placenta cases. 17 Chen et al., 2011 found the +ve rate of p53 expression in PHM and CHM were 60.9% and 85.0% respectively. 11 P53 immunoreactivity in abortion was +ve in 40% of cases in cytotrophoblasts. In PHM more than half of the cases (79.17%) were +ve in cytotrophoblasts while all cases of CHM were +ve (100.0%) in cytotrophoblasts. Hussein, 2009 showed that p53 expression was absent in the first trimester pregnancy termination and PHM whereas there was moderate nuclear positivity in CM. 18 There was statistically significant difference in p53 immunoexpression in all villous c o m p o n e n t s ( c y t o t r o p h o b l a s t s , syncytiotrophoblasts and stromal cells) between abortion and PHM, abortion and CHM and between PHM and CHM. According to the present results, P53 overexpression was useful in separating abortion from CHM and PHM, and between CHM and PHM. Kale et al., 2001 showed the same as overexpression of p53 was significantly higher in molar placenta than in non-molar (P <0.0001) and there was significant differences in p53 expression between subtypes of molar pregnancy (P <0.05). 19 Other studies found the same with the conclusion that P53 can be used to differentiate between abortion and GTD and subtypes of molar pregnancy. 13, 20, 21 Yazaki et al, 2006 showed that there is statistically a significance difference between patients of HM, patient progress to GTN or spontaneous abortion regarding the p53 immunoexpression P <0.05. 7 Other studies had investigated other tumor suppressor protein such as P63 (which is a p53 homologue) and found -ve p63 expression in cytotrophoblasts, syncytiotrophoblasts in all cases of abortion and +ve expression in all cases of PHM and CHM. 9, 22 p53 immunoexpression was valuable in differentiation between molar and non molar pregnancies and between subtypes of molar pregnancies.
Conclusion
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